Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Circulating tumor DNA (ctDNA) in urothelial carcinoma-the long-desired biomarker?]

Der Urologe. Ausg. A - 1 Nov 2021

Grunewald C Marisa, Niegisch G

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Transitional Cell
Share to Circulating Tumor DNA
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Urinary Bladder Neoplasms

Source

Identifiers

PMID: 34618167
DOI: 10.1007/s00120-021-01675-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Circulating tumor DNA (ctDNA) in urothelial carcinoma-the long-desired biomarker?]PMID 34618167Read ↗

Clinical Utility of Cell-free and Circulating Tumor DNA in Kidney and Bladder Cancer: A Critical Review of Current LiteratureSemantic proximity Read ↗

The evolving landscape and clinical utility of circulating tumor DNA across the spectrum of urothelial carcinoma: A systematic review and framework for clinical integration.Semantic proximity Read ↗

[Circulating cell-free DNA as biomarker for cancer *header*].Semantic proximity Read ↗

[Extracellular DNA in plasma--a potential diagnostic marker in oncology].Semantic proximity Read ↗

Detecting circulating tumor DNA in renal cancer: An open challengeSemantic proximity Read ↗

Next-generation sequencing (NGS) of cell-free circulating tumor DNA and tumor tissue in patients with advanced urothelial cancer: a pilot assessment of concordanceSemantic proximity Read ↗

High Sensitivity Circulating Tumor-DNA Assays in Renal Cell Carcinoma–Are we there yet?Semantic proximity Read ↗

[Clinical applications of molecular biomarkers in urothelial carcinoma of bladder].Semantic proximity Read ↗

Circulating tumor DNA analysis in advanced urothelial carcinoma: insights from biological analysis and extended clinical follow-upSemantic proximity Read ↗

Circulating mitochondrial DNA in serum: A universal diagnostic biomarker for patients with urological malignanciesSemantic proximity Read ↗

A New Paradigm of the Origins of Circulating DNA in Patients with CancerSemantic proximity Read ↗

Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.